Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 59 for “"RECIST"”.

  1. Volumenquantifizierung solider Tumoren in der Mehrzeilen- Spiralcomputertomographie am Beispiel von Lebermetastasen

    … dar. In den letzten Jahren hat das Vorgehen nach RECIST (Response Evaluation Criterias In Solid Tumors) sowohl im Rahmen klinischer Studien und als auch bei der Evaluation einer Individualtherapie eine weite Verbreitung gefunden. Diesem Konzept zufolge wird die Tumorlast anhand des maximalen …

    fu-berlin Repository record for Volumenquantifizierung solider Tumoren in der Mehrzeilen- Spiralcomputertomographie am Beispiel von Lebermetastasen (opens in a new tab)

  2. Functional thoracic imaging: diagnosis and treatment response in oncology

    … earlier than anatomical imaging using CT (RECIST), in mesothelioma (MPM) and non-small cell lung cancer (NSCLC). FLT PET-CT imaging took place in a longitudinal study with scans at baseline (PET1), approximately 24 hours after the first dose ADIPEG20 on day 2 of cycle 1 (PET2); at the end …

    kings Repository record for Functional thoracic imaging: diagnosis and treatment response in oncology (opens in a new tab) Download PDF for Functional thoracic imaging: diagnosis and treatment response in oncology (opens in a new tab)

  3. Συγκριτική αξιολόγηση τεχνικών ποσοτικής εκτίμησης δευτεροπαθών εντοπίσεων στο ήπαρ με μαγνητική τομογραφία σε ασθενείς με συμπαγείς όγκους

    … (Response Evaluation Criteria in Solid Tumors - RECIST). Beyond the above mentioned methods that have the advantage of simplicity, newer more precise methods of lesion’s measurement as volumetry have been arisen. The main aim of this study was to compare measurements of liver lesions using RECIST …

    greece Repository record for Συγκριτική αξιολόγηση τεχνικών ποσοτικής εκτίμησης δευτεροπαθών εντοπίσεων στο ήπαρ με μαγνητική τομογραφία σε ασθενείς με συμπαγείς όγκους (opens in a new tab)

  4. Therapieansprechen in der 18F-FDG PET/CT nach kombinierter Chemotherapie und regionaler Tiefenhyperthermie bei Patienten mit Weichteilsarkom

    … Kriterien (PERCIST für die 18F-FDG PET und RECIST 1.1 für die CT). Das progressionsfreie Überleben als primärer Endpunkt, sowie das Eintreten eines Lokal- oder Fernereignisses als sekundäre Endpunkte wurden mit diesen Kriterien korreliert. Der mediane Beobachtungszeitraum betrug 22,2 Monate …

    lmu-germany Repository record for Therapieansprechen in der 18F-FDG PET/CT nach kombinierter Chemotherapie und regionaler Tiefenhyperthermie bei Patienten mit Weichteilsarkom (opens in a new tab)

  5. Εκτίμηση iRECIST κριτηρίων σε ασθενείς με καρκίνο πνεύμονα. Η εμπειρία ενός κέντρου.

    … όπως τα WHO (World Health Organization) και τα RECIST (Response Evaluation Criteria in Solid Tumours), καθίστανται ανεπαρκή για την αξιολόγηση της θεραπευτικής ανταπόκρισης των ασθενών υπό ανοσοθεραπεία και κατ’ επέκταση της εκτίμησης της πορείας της νόσου αυτών. Έχουν προταθεί κριτήρια …

    athens Repository record for Εκτίμηση iRECIST κριτηρίων σε ασθενείς με καρκίνο πνεύμονα. Η εμπειρία ενός κέντρου. (opens in a new tab)

  6. Διεπεμβατικός και μετεπεμβατικός έλεγχος με CEUS στον χημειοεμβολισμό με σφαιρίδια που εκλύουν χημειοθεραπευτικά: κριτήρια ανταπόκρισης και πρόγνωσης

    … or magnetic resonance-MR) and CEUS. RECIST, mRECIST and EASL criteria of response were applied on appropriate CEUS and CT/MR images. Radiologic response was correlated with overall survival (OS) and progression-free survival (PFS). Results: There was a high degree of concordance …

    greece Repository record for Διεπεμβατικός και μετεπεμβατικός έλεγχος με CEUS στον χημειοεμβολισμό με σφαιρίδια που εκλύουν χημειοθεραπευτικά: κριτήρια ανταπόκρισης και πρόγνωσης (opens in a new tab)

  7. Lu-177 Automated Quantification Capabilities of Siemens Symbia Intevo 16.

    … Response Evaluation Criteria in Solid Tumors (RECIST). Data was collected using RECIST 10, 20, 30 and 40% thresholds of the maximum counts, with and without recovery coefficients for partial volume correction. Automated XSPECT quantification improved accuracy compared to manual 3D Flash …

    adelaide Repository record for Lu-177 Automated Quantification Capabilities of Siemens Symbia Intevo 16. (opens in a new tab)

  8. Computer-assisted volumetric tumour assessment for the evaluation of patient response in malignant pleural mesothelioma

    … Evaluation Criteria in Solid Tumours (MPM-RECIST) scheme, which provides a uni-dimensional measure of the tumour's size. However, the low CT contrast between the tumour and surrounding tissues, the extensive elongated growth pattern characteristic of MPM, and, as a consequence, the …

    oxford Repository record for Computer-assisted volumetric tumour assessment for the evaluation of patient response in malignant pleural mesothelioma (opens in a new tab)

  9. Temozolomide and Bevacizumab Therapy In Advanced Hemangiopericytoma/ Solitary Fibrous Tumor

    … as first- or second-line therapy, the overall RECIST response rate was 0%. Most patients achieved a brief duration of disease stabilization on chemotherapy, with median progression-free survival (PFS) period of 4.6 months. For the 14 patients with advanced HPC/SFT who received temozolomide and …

    uthsc Repository record for Temozolomide and Bevacizumab Therapy In Advanced Hemangiopericytoma/ Solitary Fibrous Tumor (opens in a new tab)

  10. Comparison of linear, bi-dimensional, and volumetric measurements in evaluating tumor response of hepatocellular carcinoma lesions in the arterial and portal venous phases on MRI

    … earlier judgment of treatment effect. Currently RECIST is the most widely accepted criterion in clinical trials. A modified RECIST (mRECIST) criterion was developed to take into account the unique imaging characteristics of HCC lesions. Much discussion has occurred regarding linear measurements …

    bu Repository record for Comparison of linear, bi-dimensional, and volumetric measurements in evaluating tumor response of hepatocellular carcinoma lesions in the arterial and portal venous phases on MRI (opens in a new tab)

  11. Longitudinal Imaging And Clinical Assessment Of Patients With Unresectable Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization

    … to Response Evaluation Criteria in Solid Tumors (RECIST) v.1.1 and modified RECIST. Overall survival estimates were calculated by the Kaplan-Meier method. Cox regression models were used to predict the effect of time-independent and time-dependent variables on overall survival. Results: Mean …

    jhu Repository record for Longitudinal Imaging And Clinical Assessment Of Patients With Unresectable Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization (opens in a new tab)

  12. Einflussfaktoren auf die Beurteilung des Therapieansprechens und die Prognose nach intraarterieller Therapie von Lebertumoren

    … Response Evaluation Criteria in Solid Tumors (RECIST) wurde ein neues halbautomatisch softwaregestützt ermitteltes Beurteilungskriterium, das quantitative European Association for the Study of the Liver (qEASL in cm3 und Prozent) als Prädiktor für das Gesamtüberleben (overall survival, OS) …

    fu-berlin Repository record for Einflussfaktoren auf die Beurteilung des Therapieansprechens und die Prognose nach intraarterieller Therapie von Lebertumoren (opens in a new tab)

  13. Lokoregionäre intraarterielle Chemotherapie der Leber über radiologisch- interventionell implantierte Port-Katheter

    … Ergebnisse: Beim Tumoransprechen nach RECIST lag die Response Rate in der Hepatica-Gruppe nach 3, 6, 9 und 12 Monaten jeweils bei 15,2%, 16,5%, 12,7% und 8,9% und in der Lienalis-Gruppe bei jeweils 9,3%, 7,0%, 7,0% und 4,7%. Die Disease Control Rate lag in der Hepatica-Gruppe nach 3, 6, …

    fu-berlin Repository record for Lokoregionäre intraarterielle Chemotherapie der Leber über radiologisch- interventionell implantierte Port-Katheter (opens in a new tab)

  14. LIQUID BIOPSY APPROACHES FOR CANCER DETECTION

    … a tumor fraction as compared to best response by RECIST v1.1. Molecular responders and non-responders at week 10 experienced a median PFS that was not reached and 4.5 months (HR = 5.4; 95% CI 1.7-17; p = 0.004) while patients with RECIST response and non-response at week 10 had similar PFS (median …

    jhu Repository record for LIQUID BIOPSY APPROACHES FOR CANCER DETECTION (opens in a new tab) Embargoed until 2026-12-01

  15. Papel de la tomografía por computadora en la decisión terapeútica con respecto a la clínica y radiografía simple de tórax tras quimioterapia neoadyuvante en el carcinoma de pulmón no microcítico localmente avanzado

    … de evaluación de respuesta a tumores sólidos (RECIST). Los resultados han sido analizados con el fin de evaluar hasta qué punto la TC es superior a la Rx de tórax en la interpretación de la respuesta a la QT en el PNM cuando se trata de la predicción de la indicación posterior o no de …

    oviedo Repository record for Papel de la tomografía por computadora en la decisión terapeútica con respecto a la clínica y radiografía simple de tórax tras quimioterapia neoadyuvante en el carcinoma de pulmón no microcítico localmente avanzado (opens in a new tab)

  16. Αξιολόγηση της χορήγησης σημασμένου με LU-177 DOTATATE μετά από καθετηριασμό της ηπατικής αρτηρίας σε νευροενδοκρινούς χαρακτήρα ηπατικές μεταστάσεις

    … assessment was classified according to the RECIST criteria. CT/ MRI scans were performed before and after the end of treatment; monthly ultrasound scans were performed for follow-up. Toxicity (WHO criteria) was measured using blood and urine tests for renal, hepatic and bone marrow …

    greece Repository record for Αξιολόγηση της χορήγησης σημασμένου με LU-177 DOTATATE μετά από καθετηριασμό της ηπατικής αρτηρίας σε νευροενδοκρινούς χαρακτήρα ηπατικές μεταστάσεις (opens in a new tab)

  17. Itraconazol como tratamento neoadjuvante em pacientes com carcinoma basocelular de baixo risco

    … foram avaliadas de acordo com os critérios RECIST 1.1, sendo que as lesões alvo tinham, no mínimo, 10 mm de diâmetro após a biópsia confirmatória. Vinte e seis pacientes receberam itraconazol por via oral, 200 mg duas vezes ao dia, por 60 dias antes da ressecção definitiva. O diâmetro médio …

    brazil-ufrgs Repository record for Itraconazol como tratamento neoadjuvante em pacientes com carcinoma basocelular de baixo risco (opens in a new tab)

Page 1 of 3